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Tk most frequent cause of exercise-related car iac events 
and sudden death in adults is atherosclerotic coronary artery 
diiase (1). Furthermore, the incidence ofmyocardial nfarc- 
tion (2,3), cardiac arrest (4) and sudden cardiac death (1) 
increases transiently during vigorous physical ctivity. Insome 
studies, a sign&ant proportion of adult victims of exercise- 
related sudden death ad known coronary artery disease (1). 
Therefore, it is likely that he risk of exercise-related cardiac 
events in patients with previously diagnosed coronary artcry 
diiase is higher than that in apparently healthy subjects. 
Necropsy examination f adult victims of exercise-related 
sudden death usually reveals either advanced coronary artery 
stenosis oran acute coronary artery lesion, or bo:h ($6). This 
observation suggests hat exercise-related su den death can 
result from either exercise-induced myocardial schemia nthe 
presence ofsignificant a herosclerotic coronary narrowing or 
from the progression f a lesion in a diseased coronary artery. 
There has been considerable progress in our understanding 
of coronary artery disease since the previous task force report 
(7). The previous report considered as significant only those 
lesions producing HO% narrowing of the lumen diameter. 
Such lesions are regarded as “hemodynamically significant” 
because they often restrict oronary artery flow during periods 
of increased myocardial oxygen demand. It is now appreciated 
that he morphology of less evere atherosclerotic lesions can 
be rapidly altered by plaque rupture and thrombosis, leading to 
unstable angina, myocardial nfarction and death (8,9). Acute 
plaque rupture or thrombosis is present ina high proportion of
sudden cardiac deaths in the general population (9) and has 
also been documented in victims of exercise-related cardiac 
events (5,10,11). Consequently, such hemodynamically “non- 
significant” stenoses may increase the cardiac risk of exercise 
but frequently would not be suspected bypresently available 
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uouiovasi~e testing. A coronary artery vasospastic compoueut 
te to the morbidi~ a lity of athero- 
disease and can be ipal source of 
ischemia in rare ~t~e~~ts 2). Coronary 
ost freque~tIy at arterial sites 
if the ~Iaque does not appear 
yoamica~~y significant (13). Furthermore, lesions 
that produce ischemia during exercise en if <SO% narrowed 
on a~giogra~by, often have dccrcasc 
(14), further emphasizing the limitati 
classification of coronary artery disease. Therefore, the present 
report stratifies exercise risk for cardiac events on the basis of 
llelllodyuamically significant coronary lesions but also ac- 
knowledges that risk probably also rxists for ~~iysi[)~~~~ic~~l~y 
nol~signil~c~~l~t coronary slcnoscs. 
The prevalcuce of atherosclerotic corollary artcly disease and 
the incidcncc of coronary wws increases with advancing age. 
Cilrdiilc WtXltS in athletes c30 yeiNS of ilf$ itl’c’ Ollly rilrdy WI&Xl 
to athcrosclcrotic coronaty artery discasc (1S), and this diagnosis 
is extremely rare iIS it cause of cxcriio~~-rclatc 
school- or college-age athletes. Indeed, coronary artery events in 
athletes ~30 years old should initiate a search for causes of 
premature atherosclerosis, such as familial hypercholesterolemia, 
and other causes of coronary disease, such as inflammatory 
art&is and especially cocaine use. However, ischemic heart 
disease is the dominant cause of exertion-related sudden death in 
adults, and the recommendations of the present task force apply 
primarily to the adult compctitivc athletic population. 
Diagnosis 
For the purpose of the present report wc will consider the 
diagnosis of coronary artery discasc cstahlishcd if I) coronary 
angiography demonstrates coronary artery atherosclerotic lu- 
men narrowing of at least one major coronary artery; 2) a 
history of a myocardial infarction can be confirmed by conven- 
tional electrocardiography or enzyme criteria; or 3) a history 
suggestive of angina pectoris is buttressed by objective data, 
such as an ischemic ST segment or abnormal myocardial 
perfusion response to exercise. 
Risk Assessment 
No data exist that directly relate the presence and severity 
of coronary artery disease to the risk of participating in 
competitive athletics. Nevertheless, the prognosis in patients 
with coronary artery disease worsens with increasing extent of 
disease, left ventricular dysfunction, inducible ischemia and 
electrical instability. The latter three factors have been shown 
to be present in a high proportion of patients after cardiac 
rehabilitation who suffer cardiac arrest during exercise (16). 
Consequently, it is probable that the risk of cardiac events 
occurring during competitive exercise increases with the pres- 
ence of increasingly severe coronary artery disease, left ven- 
tricular dysfunction and ventricular arrhythmias. It is also 
likely that the risk increases with the intensity of the corn 
itive sport and the intensity of the participant’s el8fort. 
1. Athletes with previously diagnosed coronary artery dis- 
ease undergoing evaluation for competitive athletics should 
have their left ventricular function assessed 
dimeusioual echocardiography, radionuclide angiography or 
left ventricular angiography. 
2. These athletes should undergo maximal treadmill or 
bicycle exercise testing to assess their exercise capacity. In 
addition, when feasible, exercise testing should approximate 
closely the cardiovascular and metabolic demands of the 
planned competitive event and its training regimen. 
3. The presence or absence of provocable myocardial isch- 
emia should also be determined by exercise electrocardio- 
graphy, radionuclide perfusion imaging, exercise echocardiog- 
raphy or subjective cvidcncc of ischemia. 
levels of risk can be defined on the basis of testing. 
ly increased risk Athletes with coronary artery dis- 
ease diagnosed by noninvasive or invasive testing are judged to 
be at only mildly increased risk if they demonstrate each of the 
following: 
1. Normal or near-normal left ventricular systolic function 
at rest (i.e., ejection fraction >50%). 
2. Normal exercise tolerance for age, demonstrated during 
treadmill or cycle ergometer exercise testing: >I0 metabolic 
equivalents (METS), or >35 &/kg-min if ~50 years old; >9 
METS, or >3l ml @/kg-min for 50 to 59 years old; >X METS, 
or >28 ml &/kg-min, if 60 to 69 years old; and >7 METS, or 
>24 ml Odkg-min, if ~70 years old. 
3. Absence of exercise-induced &hernia by exercise testing. 
4. Absence of exercise-induced complex ventricular ar- 
rhythmias, including ventricular tachycardia. 
5. Absence of hemodynamically significant stenosis in all 
major coronary arteries (generally regarded as ~50% lumen 
diameter narrowing) if coronary angiography is performed; or 
successful myocardial rcvascularizztion by surgical or percuta- 
neous techniques. 
Substantially increased risk. Athletes with coronary artery 
disease identified by noninvasive or invasive testing are judged 
to be at substantially increased risk if they demonstrate any of 
the following: 
1. Impaired left ventricular systolic function at rest (i.e., 
ejection fraction GO%). 
2. Evidence of exercise-induced myocardial ischemia. 
3. Evidence of exercise-induced complex ventricular ar- 
rhythmias, including ventricular tachycardia. 
4. Hemodynamically significant stenosis of a major coro- 
nary artery (generally regarded as 250% lumen diameter 
narrowing) if coronary angiography was performed. 
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Within the substantially increased risk group, an exercise- 
related cardiac event is probably more likely with increasing 
severity of coronary atherosclerosis, cardiac dysfunction, 
exercise-induced ischemia and cardiac arrhythmias (16). 
Because most athletes will compete while taking their 
png&ed drugs, performing maximal exercise testing with 
these usual medications may more accurately approximate the 
competitive situation. A more conservative approach is to 
perform exercise testing after athletes have been withdrawn 
from anti-&chemic cardiac medications, such as nitrates, beta- 
adrenergic and calcium channel blocking agents. The latter 
approach should be considered if compliance with medical 
therapy is a potential problem. It should be noted that beta- 
blockers are prohibited in certain competitive sports 
Routine coronary arteriography is not ncccssarily required 
to determine eligibility for competition in patients with known 
coronary artery disease, although such testing may be useful in 
overall patient management. In addition, coronary artcriogra- 
phy is recommended in athletes with cxcrcise-induced isch- 
emia who choose to participate in sports against medical 
advice, Such studies, in this instance, are intended in part to 
identify coronary lesions that may be better managed by 
percutaneous or surgical myocardial revascularization proce- 
dures to relieve exercise-induced ischemia and potentially to 
reduce exercise-related risk. 
The task force wishes to emphasize that the following 
recommendations are prepared as a guideline for permitting 
participation in cumpdtive sports. The restrictions in the 
following recommendations, therefore, should not be misinter- 
preted as an injunction against regular physical activity as 
opposed to athletic competition. Indeed, regular physical 
activity is recommended for patients with coronary artcty 
disease for its general cardiovascular benctits. 
Recommendations 
I. Athletes in the mildly increased risk group can partici- 
pate in low dynamic and low/moderate static competitive 
sports (classes IA and IIA [see Table I in Classification of 
Sports]) and should avoid intensely competitive situations. We 
recognize that selected athletes with mildly increased risk may 
be permitted to compete in sprts of higher levels of intensity 
when their overall clinical profile suggests very low exercise 
risk. All athletes should understand that the risk of a cardiac 
event with exertion is probably increased once coronary artery 
disease is present. Athletes with mildly increased risk engaging 
in competitive sports should undergo reevaluation of their risk 
stratification at least annually. 
2. Athletes in the substantially increased risk category 
should generally be restricted to low intensity competitive 
TftS (CUSS IA). Within this substantially increased risk group, 
even low intensity competitive activity should be prohibited for 
that SUbgrOUp of patients judged to be at the highest risk 
because of severe abnormalities in left ventricular function 
(ejection fraction <40%), exercise intolerance or exercise- 
induced cardiac arrhythmias (i.e., ventricular tachycardia). 
Athletes allowed to participate in low intensity activity should 
be reevaluated at least every 6 months and should undergo 
repeat exercise testing at least yearly. 
3. Athletes should be informed of the nature of prodromal 
symptoms and should be instructed to cease promptly their 
sports activity and to contact their physician if symptoms 
appear. Physicians should be aware that competitive athletes 
may minimize symptoms that appear during exertion. 
4. Those with a recent myocardial infarction or myocardial 
revascularization should be instructed to cease their athletic 
activity until recovery is deemed complete. After this recuper- 
ation period, the risk and activity level should be defined as in 
recommendations 1 and 2. 
It must bc emphasized that even athletes identified as being 
at mildly increased risk and permitted to participate in low 
dynamic and low/moderate static competitive sports (classes 
IA and IIA) cannot bc assured that such participation will not 
increase the risk of cardiac events. Indeed, it is probable that 
any excrcisc transiently posts ~onte increased risk during 
activity for this group (3.4) and that this risk is greater for 
patients with diagnosed coronary artery disease than that for 
the general population. Thus, the ultimate judgment as to 
whether a patient with coronary artery disease should partici- 
pate in competitive sports must not be based on false assur- 
anccs of absent risk but on probability estimates. The physician 
can only indicate after testing that the pnticnt identilied as 
being at mildly increased risk is /cs.~ like& to cxpcricncc a 
cardiac event as a result of athletic competition. This risk 
cannot be precisely quantified at prcscnt. The patient, coaches 
and other involved persons must be made aware of the 
possibility of an exercise-induced cardiac event in patients with 
atherosclerotic coronary artery disease. The final decision on 
participation should be based cn the magnitude of increased 
risk deemed acceptable for each patient. 
Coronary Artery Vasospasm 
Coronary artery vasospasm can be provoked by physical 
exertion (12,17). Vasospasm is most frequently observed at 
coronary sites damaged by atherosclerosis (13) and is less fre- 
quent in patients with angiographically normal coronary arteries 
(12). A vasospastic contribution to ischemia should be suspected 
when there is marked variation in the exercise threshold for 
angina (12), when electmrdiographic (ECG) changes are pro- 
duced in symptomatic patients by hyperventilation (18) and when 
there is evidence of myocardial ischemia with minimally ob- 
structed coronary arteries. Risk associated with participation in 
sports for athletes with coronary artery spasm is not known, but 
exercise-related myocardial infarction has been reported in ath- 
letes with angiograpbically normal coronary arteries (19,20), and 
wuospasm has been documented in athletes with coronary atb- 
erosclemsis who experienced cardiac events during exercise (11). 
Consequently, we recommend a cautious approach to patients 
with documented coronary vasospasm until the risk of physical 
exertion for these patients is better defined. 
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hletes with coronary atherosclerosis. 
2. Athletes with coronary vasospasm documented atrest or 
with exercise and angiographically normal coronary arteries or 
nonsignificant coronary atherosclerosis (generally regarded as 
~50% lumen diameter narrowing) should be restricte 
intensity competitive sports (class IA). Tbis restriction should 
be reevaluated at least ammally because some patients with 
coronary vasospasm ay experience spontaneous remission. 
artery disease is different from tha 
hearts: Proximal discrete stenosis of 
quent; the disease is diffuse, and dista 
collateral vessel development is rare, ssibly because of the 
rapidity with which the disease develo 
include subintimal mononuclear cell infiltration, suggesting that 
immunologic factors may contribute to the disease process (22). 
Noninvasive t sting for coronary artery disease isless sensitive in
the transplant recipient because many atients do not develop 
symptoms of ischemia because of card denervation and be- 
cause provocative myocardial perfusion I ging may fail to detect 
ischemia (21). However, angiography can also underestimate 
disease severity because of the diifirse and often concentric 
arterial narrowing (23). 
Evaluation 
1. Cardiac transplant recipients participating in competi- 
tive athletics hould undergo yearly maximal exercise testing 
using a protocol designed to simulate the cardiac and meta- 
bolic demands of the competitive event and its training. 
2. Such patients should also undergo annual coronary 
angiography. 
Recommendations 
1. Decisions as to the feasibility of athletic ompetition for 
cardiac transplant recipients hould be made in conjunction 
with a cardiologist expert in the management of these patients. 
2. Athletes without advanced coronary disease and with 
normal exercise tolerance for age (as defined earlier) can 
generally participate in all competitive sports. 
3. Athletes with reduced exercise capacity but without 
advanced coronary artery disease can participate in sports 
commensurate with their exercise capacity. 
4. Athletes with documented advanced coronary artery 
disease should generally be restricted to low intensily compet- 
itive sports (class IA). 
involves the heart, including an a 
of potential consequence for the 
onary artery aneurysms may persist, 
or stenosis may occur, as a result of healing aneurysms. Even 
those with apparent total resolution ofcoronary artery abnormal- 
ities could still have subclinical functional or histologic abnormal- 
ities of the coronary arteries, and the long-term risk of developing 
coronary atherosclerosis is not known. Coronary artery aneu- 
rysms can be identified and evaluated longitudinally with two- 
dimensional acardiography, although coronary angiography 
may be requi in selected instances. The predictive accuracy of
routine xercise t sting for the evaluation of myocardial ischemia 
in the patient with Kawasaki disease with a coronary artery 
aneurysm is low. Exercise testing with nuclear perfusion scans 
may be required to adequately evaluate this patient group (26). 
1. Athletes with Kawasaki disease who have never had 
coronary involvement or who have documented resolution of 
any previous aneurysms can participate in all competitive 
sports. Long-term periodic follow-up is suggested because the 
natural history of the disease is unknown. 
2. Ath!etes who have minor residua! abnormalities after 
resolution of coronary aneurysms should be considered at 
mildly increased risk, as described earlier, and can participate 
in low static and low/moderate dynamic ompetittve sports 
(classes IA and IB). 
3. Athletes with persistent coronary artery aneurysm or ste- 
nosis should be considered at substantially increased risk and 
should be restricted tolow intensity competitive sports (class IA). 
4. Evidence of intermittent myocardial ischemia should 
preclude participation i all competitive sports. 
Myocardial bridging is a condition in which a major epicar- 
dial coronary artery (most commonly the left anterior descend- 
ing and usually unassociated with atherosclerosis) i  “tun- 
neled” within and completely surrounded by left ventricular 
myocardium for at least a portion of its course. On occasion, 
such arteries have been shown to have substantial compression 
and constriction during systole. Myocardial bridging is found in 
-25% of hearts examined at necropsy (27,28). Consequently, 
most tunneled epicardial coronary arteries appear to be of 
little clinical significance and rarely produce clinical evidence 
of myocardial ischemia. Nevertheless, this vascular malforma- 
tion has occasionally been associated with exercise-related 
sudden death (27,29) and exercise-induced angina pectoris 
(30). Surgical resection of the myocardial bridge in selected 
symptomatic patients has been shown to reduce angina (30) 
and improve myocardial blood flow (31). 
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Rceommendatioas 
1. Athletes with myocardial bridging of an epicardial cor- 
onary artery and no evidence of myocardia! ixhemia at rest or 
during exercise can participate in ail competitive sports. 
2. Athletes with myocardial bridging of an epicardial coronary 
artery and objective vidence of myocardial ischemia should be 
restricted to low intensity competitive sports (claxs IA). 
Recommendations for other coronary artery anomalies, 
including anomalous origin of the left main coronary artery, 
are included in Task Force 1. 
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General Considerations 
Guidelines for athletic participation are needed to reduce 
the risk for arrhythmia-related morbidity or mortality. How- 
ever, it is often difficult o establish the importance ofa cardiac 
rhythm disturbance in assessing an athlete’s eligibility for 
competition. Few data exist hat have been obtained prospec- 
tively from well designed, scientifically acceptable studies to 
